DE69329108T2
(de)
*
|
1992-03-02 |
2001-03-22 |
Bioeng Inc |
Verfahren zur inaktivierung von viren
|
FR2699408B1
(fr)
*
|
1992-12-21 |
1995-03-24 |
Bioland |
Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
|
FR2735372B1
(fr)
*
|
1995-06-13 |
1997-09-05 |
Bioland |
Nouvelles utilisations d'un courant de dioxyde de carbone supercritique a titre d'agent antiviral
|
US5723012A
(en)
*
|
1993-12-09 |
1998-03-03 |
Bioland |
Uses for a current of supercritical carbon dioxide as an antiviral agent
|
AUPN030794A0
(en)
|
1994-12-22 |
1995-01-27 |
Aruba International Pty Ltd |
Discontinuous plasma or serum delipidation
|
US6149864A
(en)
*
|
1998-06-25 |
2000-11-21 |
Massachusetts Institute Of Technology |
Supercritical fluid sterilization method
|
WO2001047566A1
(fr)
*
|
1999-12-27 |
2001-07-05 |
Kabushiki Kaisha Sr Kaihatsu |
Procede et appareil permettant de desinfecter/steriliser des instruments medicaux
|
US20090017069A1
(en)
*
|
2000-06-29 |
2009-01-15 |
Lipid Sciences, Inc. |
SARS Vaccine Compositions and Methods of Making and Using Them
|
US7407662B2
(en)
*
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified viral particles with immunogenic properties and reduced lipid content
|
US7439052B2
(en)
*
|
2000-06-29 |
2008-10-21 |
Lipid Sciences |
Method of making modified immunodeficiency virus particles
|
US7407663B2
(en)
*
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified immunodeficiency virus particles
|
AUPQ846900A0
(en)
*
|
2000-06-29 |
2000-07-27 |
Aruba International Pty Ltd |
A vaccine
|
EP1409108A4
(de)
*
|
2001-06-25 |
2007-11-14 |
Lipid Sciences Inc |
Hohlfaserberührungssysteme zur entfernung von lipiden aus fluiden
|
WO2003000381A1
(en)
*
|
2001-06-25 |
2003-01-03 |
Lipid Sciences, Inc. |
Hollow fiber contactor systems for removal of lipids from fluids
|
EP1412045A4
(de)
*
|
2001-06-25 |
2007-05-02 |
Lipid Sciences Inc |
Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren
|
US20060060520A1
(en)
*
|
2001-06-25 |
2006-03-23 |
Bomberger David C |
Systems and methods using a solvent for the removal of lipids from fluids
|
US6991727B2
(en)
*
|
2001-06-25 |
2006-01-31 |
Lipid Sciences, Inc. |
Hollow fiber contactor systems for removal of lipids from fluids
|
US7033813B2
(en)
*
|
2001-09-05 |
2006-04-25 |
Trevor P Castor |
Inactivated vaccines for aids and other infectious diseases
|
US7291352B2
(en)
|
2001-10-03 |
2007-11-06 |
Herbalscience Llc |
Methods and compositions for oral delivery of Areca and mate' or theobromine
|
US7105185B2
(en)
|
2001-10-03 |
2006-09-12 |
Herbalscience, Llc |
Kavalactone profile
|
US20050053678A1
(en)
*
|
2001-10-03 |
2005-03-10 |
Gow Robert T. |
Methods and compositions for betel nut chewing gum
|
US20050069596A1
(en)
*
|
2001-10-03 |
2005-03-31 |
Gow Robert T. |
Compositions and methods comprising kava and anti-anxiety compounds
|
US7029707B2
(en)
*
|
2001-10-03 |
2006-04-18 |
Herbalscience, Llc |
Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
|
US7037524B2
(en)
*
|
2001-10-03 |
2006-05-02 |
Herbalscience, Llc |
Oral delivery of a botanical
|
US7001620B2
(en)
|
2001-10-03 |
2006-02-21 |
Herbal Science, Llc |
Kavalactone product
|
US7008591B2
(en)
*
|
2001-10-17 |
2006-03-07 |
Edwards Lifesciences Corporation |
Supercritical fluid extraction process for tissue preparation
|
JP2005538148A
(ja)
*
|
2002-08-26 |
2005-12-15 |
リピド サイエンスィズ インコーポレイテッド |
脱脂タンパク質粒子を使用したアルツハイマー病治療
|
US20050037025A1
(en)
*
|
2002-10-03 |
2005-02-17 |
Gow Robert T. |
Methods and compositions comprising kava and mate' or theobromine
|
US7777006B2
(en)
|
2002-12-31 |
2010-08-17 |
Csl Behring L.L.C. |
Method for purification of alpha-1-antitrypsin
|
JP2007527387A
(ja)
*
|
2003-07-03 |
2007-09-27 |
リピッド サイエンシーズ,インコーポレイテッド |
脂質含量の低下したhdlの粒子誘導体を製造するための方法及び装置
|
US7393826B2
(en)
|
2003-07-03 |
2008-07-01 |
Lipid Sciences, Inc. |
Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
|
US6960803B2
(en)
*
|
2003-10-23 |
2005-11-01 |
Silicon Storage Technology, Inc. |
Landing pad for use as a contact to a conductive spacer
|
US7294353B2
(en)
*
|
2003-10-24 |
2007-11-13 |
Herbalscience, Llc |
Methods and compositions comprising ilex
|
US7279184B2
(en)
*
|
2003-10-24 |
2007-10-09 |
Herbalscience, Llc |
Methods and compositions comprising Ilex
|
US8328876B2
(en)
*
|
2003-12-31 |
2012-12-11 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
US20070231788A1
(en)
*
|
2003-12-31 |
2007-10-04 |
Keyvan Behnam |
Method for In Vitro Assay of Demineralized Bone Matrix
|
US7387749B2
(en)
*
|
2004-02-20 |
2008-06-17 |
Wayne State University |
Method of delaminating aggregated particles with a coating agent in a substantially supercritical fluid
|
TWI302944B
(en)
*
|
2004-07-12 |
2008-11-11 |
|
Method for removing virus activity from biological materials
|
CN1318581C
(zh)
*
|
2004-07-13 |
2007-05-30 |
南玮实业股份有限公司 |
利用超临界流体去除冠状病毒活性的方法
|
US20060269928A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Aphios Corporation |
Compositions, methods and apparatus for supercritical fluid virus inactivation
|
WO2007053850A2
(en)
|
2005-11-01 |
2007-05-10 |
Osteotech, Inc. |
Bone matrix compositions and methods
|
KR20080005678A
(ko)
*
|
2006-07-10 |
2008-01-15 |
삼성전자주식회사 |
인쇄회로기판 및 이를 갖는 전자장치
|
CA2690457C
(en)
*
|
2007-06-15 |
2018-02-20 |
Osteotech, Inc. |
Bone matrix compositions and methods
|
US9554920B2
(en)
*
|
2007-06-15 |
2017-01-31 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions having nanoscale textured surfaces
|
WO2008157497A2
(en)
*
|
2007-06-15 |
2008-12-24 |
Osteotech, Inc. |
Method of treating tissue
|
WO2008157492A2
(en)
|
2007-06-15 |
2008-12-24 |
Osteotech, Inc. |
Osteoinductive demineralized cancellous bone
|
US9492278B2
(en)
|
2007-07-10 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Delivery system
|
US20110054408A1
(en)
*
|
2007-07-10 |
2011-03-03 |
Guobao Wei |
Delivery systems, devices, tools, and methods of use
|
EP2183268B1
(de)
|
2007-08-17 |
2012-10-10 |
CSL Behring GmbH |
Verfahren zur aufreinigung von alpha-1-antitrypsin und apolipoprotein a-i
|
WO2009052492A2
(en)
|
2007-10-19 |
2009-04-23 |
Osteotech, Inc. |
Demineralized bone matrix compositions and methods
|
US8679176B2
(en)
|
2007-12-18 |
2014-03-25 |
Cormatrix Cardiovascular, Inc |
Prosthetic tissue valve
|
US8257434B2
(en)
|
2007-12-18 |
2012-09-04 |
Cormatrix Cardiovascular, Inc. |
Prosthetic tissue valve
|
WO2010093955A1
(en)
|
2009-02-12 |
2010-08-19 |
Osteotech,Inc. |
Segmented delivery system
|
WO2010148117A1
(en)
|
2009-06-17 |
2010-12-23 |
Scantibodies Laboratory, Inc. |
Therapeutic and diagnostic affinity purified specific polyclonal antibodies
|
US8945895B2
(en)
|
2009-07-31 |
2015-02-03 |
Baxter International Inc. |
Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
|
SG194880A1
(en)
|
2011-05-27 |
2013-12-30 |
Cormatrix Cardiovascular Inc |
Sterilized, acellular extracellular matrix compositions and methods ofmaking thereof
|
US8956566B2
(en)
|
2012-03-12 |
2015-02-17 |
Pure Biosolutions, Llc |
System and method for virus inactivation
|
JP6182210B2
(ja)
*
|
2012-06-29 |
2017-08-16 |
イー・エム・デイー・ミリポア・コーポレイシヨン |
タンパク質精製プロセス中のウイルスの不活性化方法
|
US8791054B2
(en)
*
|
2012-09-27 |
2014-07-29 |
Halliburton Energy Services, Inc. |
Methods of converting an inactive biocide into an active biocide using a chemical reaction
|
RU2713126C2
(ru)
|
2014-10-24 |
2020-02-03 |
Джензим Корпорейшн |
Способ предотвращения контаминации системы
|
EP3088006A1
(de)
*
|
2015-04-28 |
2016-11-02 |
Bayer Technology Services GmbH |
Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor
|
JP2018082987A
(ja)
*
|
2016-11-25 |
2018-05-31 |
株式会社日立製作所 |
ウイルス不活化方法及びウイルス不活化装置
|
WO2019104237A1
(en)
|
2017-11-22 |
2019-05-31 |
Hdl Therapeutics, Inc. |
Systems and methods for priming fluid circuits of a plasma processing system
|
AU2018396009A1
(en)
|
2017-12-28 |
2020-07-16 |
Hdl Therapeutics, Inc. |
Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
|
RU2691983C1
(ru)
*
|
2018-02-27 |
2019-06-19 |
Общество с ограниченной ответственностью "Матрифлекс" |
Способ очистки, модификации и стерилизации производных костной ткани и кожного матрикса с использованием сверхкритического флюида
|
KR102565569B1
(ko)
*
|
2018-03-30 |
2023-08-09 |
아사히 가세이 메디컬 가부시키가이샤 |
혈액 정화기 및 그 제법
|
WO2021048221A1
(en)
*
|
2019-09-09 |
2021-03-18 |
Valneva Austria Gmbh |
Inactivation process for viruses
|
WO2023063933A1
(en)
*
|
2020-10-12 |
2023-04-20 |
Castor Trevor P |
Apparatus and method for inactivating viruses and pathogens in human plasma units
|
WO2022109430A1
(en)
*
|
2020-11-22 |
2022-05-27 |
Castor Trevor P |
Sustained release inactivated vaccines
|
WO2023063932A1
(en)
*
|
2021-10-12 |
2023-04-20 |
Castor Trevor P |
Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma
|